Myelodysplastic syndromes : Incidence an
β
Xiaomei Ma; Monique Does; Azra Raza; Susan T. Mayne
π
Article
π
2007
π
John Wiley and Sons
π
English
β 133 KB
π 1 views
## Abstract ## BACKGROUND. Myelodysplastic syndromes (MDS) became reportable to the Surveillance, Epidemiology, and End Results (SEER) Program (the United States cancer surveillance program) in 2001. This provided the first opportunity to examine the incidence and survival of patients with MDS in